Onconetix CEO Karina Fedasz to step down, David White to succeed

robot
Abstract generation in progress

Onconetix (ONCO) announced that Karina Fedasz will step down as interim CEO, with David White appointed as her successor, effective March 18. Fedasz will remain as interim CFO. Sammy Dorf has also been appointed to the company’s board of directors and audit committee.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments